Inhibrx Biosciences Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Inhibrx Biosciences stock has a consensus rating of "Buy" and an average price target of $277.5. The average 1-year stock price forecast is 191.16% higher than the current stock price, while the lowest is $230 (+141.32%) and the highest is $325 (+240.99%).

Price Target: $277.5 (+191.16%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$230	$277.5	$277.5	$325
Change	+141.32%	+191.16%	+191.16%	+240.99%

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	0	0	0	1	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dara Azar Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $325	Buy	Maintains	$325	+240.99%	Jun 2, 2026
Oliver McCammon LifeSci Capital	LifeSci Capital	Buy Maintains $230	Buy	Maintains	$230	+141.32%	May 16, 2026

Financial Forecast

Revenue This Year

n/a

from 1.30M

-100.00%

from 1.30M

Revenue Next Year

57.18M

EPS This Year

-9.26

from -9.04

EPS Next Year

-6.30

from -9.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	7.23M	1.32M	1.80M	200.00K	1.30M	-
Revenue Growth	-43.89%	-81.81%	36.88%	-88.89%	550.00%	-100.00%
Operating Income	-76.56M	-115.32M	-219.19M	-222.29M	-135.03M	-160.92M
Net Income	-81.77M	-115.33M	-241.36M	1.69B	-140.06M	-173.62M
EPS	-	-	-	-	-9.04	-9.26
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-9.26
Avg	-9.26
Low	-9.26

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-